![Frontiers | Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practice Frontiers | Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practice](https://www.frontiersin.org/files/Articles/1266369/fonc-13-1266369-HTML/image_m/fonc-13-1266369-g002.jpg)
Frontiers | Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practice
![Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer - ScienceDirect Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1558767323000228-ga1.jpg)
Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer - ScienceDirect
![PDF) Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy PDF) Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy](https://www.researchgate.net/profile/Ferdinando-Calabria/publication/221734569/figure/tbl1/AS:667175266295817@1536078387367/Registered-PSA-values-in-patients-with-negative-or-positive-PET-CT_Q320.jpg)
PDF) Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy
GitHub - conan-koh123/Calculating-PSA-Doubling-Time-for-many-patients: R code to calculate PSA doubling time (in months) for many patients
Learn about PatchMyPC ROI calculator with Bryan Dam, Jordan Benzing, and George Williams | Patch My PC posted on the topic | LinkedIn
![POCKET.MD - PSA DT Calculator for iPhone, PSA DT CALCULATOR è la nuova app di Janssen che accompagna il medico nella valutazione del tumore a... POCKET.MD - PSA DT Calculator for iPhone, PSA DT CALCULATOR è la nuova app di Janssen che accompagna il medico nella valutazione del tumore a...](http://www.pocket.md/images/appImages/screenshots/3046_1882869111.jpeg)
POCKET.MD - PSA DT Calculator for iPhone, PSA DT CALCULATOR è la nuova app di Janssen che accompagna il medico nella valutazione del tumore a...
![Frontiers | Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate Frontiers | Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate](https://www.frontiersin.org/files/Articles/1123934/fendo-14-1123934-HTML-r1/image_m/fendo-14-1123934-g001.jpg)
Frontiers | Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://cdnintech.com/media/chapter/41807/1512345123/media/image11.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
PSA data. (A) Baseline PSA levels are shown for each patient in the... | Download Scientific Diagram
![Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer | Scientific Reports Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-20319-z/MediaObjects/41598_2022_20319_Fig1_HTML.png)
Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer | Scientific Reports
![Clinical significance of the prostate-specific antigen doubling time prior to and following radical prostatectomy to predict the outcome of prostate cancer Clinical significance of the prostate-specific antigen doubling time prior to and following radical prostatectomy to predict the outcome of prostate cancer](https://www.spandidos-publications.com/article_images/mco/6/2/mco-06-02-0249-g00.jpg)
Clinical significance of the prostate-specific antigen doubling time prior to and following radical prostatectomy to predict the outcome of prostate cancer
![The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer | Prostate Cancer and Prostatic Diseases The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fpcan.2013.40/MediaObjects/41391_2014_Article_BFpcan201340_Fig1_HTML.jpg)